2016.06.10

Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter.

Abstract

Multistep proteolytic mechanisms are essential for converting proprotein precursors into active peptide neurotransmitters and hormones. Cysteine proteases have been implicated in the processing of proenkephalin and other neuropeptide precursors. Although the papain family of cysteine proteases has been considered the primary proteases of the lysosomal degradation pathway, more recent studies indicate that functions of these enzymes are linked to specific biological processes. However, few protein substrates have been described for members of this family. We show here that secretory vesicle cathepsin L is the responsible cysteine protease of chromaffin granules for converting proenkephalin to the active enkephalin peptide neurotransmitter. The cysteine protease activity was identified as cathepsin L by affinity labeling with an activity-based probe for cysteine proteases followed by mass spectrometry for peptide sequencing. Production of [Met]enkephalin by cathepsin L occurred by proteolytic processing at dibasic and monobasic prohormone-processing sites. Cellular studies showed the colocalization of cathepsin L with [Met]enkephalin in secretory vesicles of neuroendocrine chromaffin cells by immunofluorescent confocal and immunoelectron microscopy. Functional localization of cathepsin L to the regulated secretory pathway was demonstrated by its cosecretion with [Met]enkephalin. Finally, in cathepsin L gene knockout mice, [Met]enkephalin levels in brain were reduced significantly; this occurred with an increase in the relative amounts of enkephalin precursor. These findings indicate a previously uncharacterized biological role for secretory vesicle cathepsin L in the production of [Met]enkephalin, an endogenous peptide neurotransmitter.

Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter.

supplementary figure

2016.06.10 Read More »

Journal club 2016. 05. 27.

Osthole inhibits histamine-dependent itch via modulating TRPV1 activity

srep25657

Osthole, an active coumarin isolated from Cnidium monnieri (L.) Cusson, has long been used in China as an antipruritic herbal medicine; however, the antipruitic mechanism of osthole is unknown. We studied the molecular mechanism of osthole in histamine-dependent itch by behavioral test, Ca2+ imaging,
and electrophysiological experiments. First, osthole clearly remitted the scratching behaviors of mice induced with histamine, HTMT, and VUF8430. Second, in cultured dorsal root ganglion (DRG) neurons, osthole showed a dose-dependent inhibitory e ect to histamine. On the same neurons, osthole also decreased the response to capsaicin and histamine. In further tests, the capsaicin-induced inward currents were inhibited by osthole. These results revealed that osthole inhibited histamine-dependent itch by modulating TRPV1 activity. This study will be helpful in understanding how osthole exerts anti- pruritus e ects and suggests that osthole may be a useful treatment medicine for histamine-dependent itch.

Journal club 2016. 05. 27. Read More »

2016.05.20

Hydrogen sulfide-induced itch requires activation of Cav3.2 T-type calcium channel in mice.

Abstract

The contributions of gasotransmitters to itch sensation are largely unknown. In this study, we aimed to investigate the roles of hydrogen sulfide (H2S), a ubiquitous gasotransmitter, in itch signaling. We found that intradermal injection of H2S donors NaHS or Na2S, but not GYY4137 (a slow-releasing H2S donor), dose-dependently induced scratching behavior in a μ-opioid receptor-dependent and histamine-independent manner in mice. Interestingly, NaHS induced itch via unique mechanisms that involved capsaicin-insensitive A-fibers, but not TRPV1-expressing C-fibers that are traditionally considered for mediating itch, revealed by depletion of TRPV1-expressing C-fibers by systemic resiniferatoxin treatment. Moreover, local application of capsaizapine (TRPV1 blocker) or HC-030031 (TRPA1 blocker) had no effects on NaHS-evoked scratching. Strikingly, pharmacological blockade and silencing of Cav3.2 T-type calcium channel by mibefradil, ascorbic acid, zinc chloride or Cav3.2 siRNA dramatically decreased NaHS-evoked scratching. NaHS induced robust alloknesis (touch-evoked itch), which was inhibited by T-type calcium channels blocker mibefradil. Compound 48/80-induced itch was enhanced by an endogenous precursor of H2S (L-cysteine) but attenuated by inhibitors of H2S-producing enzymes cystathionine γ-lyase and cystathionine β-synthase. These results indicated that H2S, as a novel nonhistaminergic itch mediator, may activates Cav3.2 T-type calcium channel, probably located at A-fibers, to induce scratching and alloknesis in mice.

Hydrogen sulfide induced itch

2016.05.20 Read More »

2016.05.13

Regulated proenkephalin expression in human skin and cultured skin cells.

Abstract

Skin responds to environmental stressors via coordinated actions of the local neuroimmunoendocrine system. Although some of these responses involve opioid receptors, little is known about cutaneous proenkephalin expression, its environmental regulation, and alterations in pathology. The objective of this study was to assess regulated expression of proenkephalin in normal and pathological skin and in isolated melanocytes, keratinocytes, fibroblasts, and melanoma cells. The proenkephalin gene and protein were expressed in skin and cultured cells, with significant expression in fibroblasts and keratinocytes. Mass spectroscopy confirmed Leu- and Met-enkephalin in skin. UVR, Toll-like receptor (TLR)4, and TLR2 agonists stimulated proenkephalin gene expression in melanocytes and keratinocytes in a time- and dose-dependent manner. In situ Met/Leu-enkephalin peptides were expressed in differentiating keratinocytes of the epidermis in the outer root sheath of the hair follicle, in myoepithelial cells of the eccrine gland, and in the basement membrane/basal lamina separating epithelial and mesenchymal components. Met/Leu-enkephalin expression was altered in pathological skin, increasing in psoriasis and decreasing in melanocytic tumors. Not only does human skin express proenkephalin, but this expression is upregulated by stressful stimuli and can be altered by pathological conditions.

Regulated proenkephalin expression in human skin and cultured skin cells

supplementary data regulated proenkephalin

2016.05.13 Read More »

Journal Club 2016. 4. 29

Regulation of hepatic EAAT-2 glutamate transporter expression in human liver cholestasis.

AIM:

To investigate the activity and expression of EAAT2 glutamate transporter in both in vitro and in vivo models of cholestasis.

METHODS:

This study was conducted on human hepatoblastoma HepG2 cell cultures, the liver of bile duct ligated rats and human specimens from cholestatic patients. EAAT2 glutamate transporter activity and expression were analyzed using a substrate uptake assay, immunofluorescence, reverse transcription-polymerase chain reaction, and immunohistochemistry, respectively.

RESULTS:

In HepG2 cells, cholestasis was mimicked by treating cells with the protein kinase C activator, phorbol 12-myristate 13-acetate. Under such conditions, EAAT2 transporter activity was decreased both at the level of substrate affinity and maximal transport velocity. The decreased uptake was correlated with intracellular translocation of EAAT2 molecules as demonstrated using immunofluorescence. In the liver of bile duct ligated rats, an increase in EAAT2 transporter protein expression in hepatocytes was demonstrated using immunohistochemistry. The same findings were observed in human liver specimens of cholestasis in which high levels of γ-glutamyl transpeptidase were documented in patients with biliary atresia and progressive familial intrahepatic cholestasis type 3.

CONCLUSION:

This study demonstrates the alteration in glutamate handling by hepatocytes in liver cholestasis and suggests a potential cross-talk between glutamatergic and bile systems.

Regulation of hepatic EAAT-2 glutamate transporter expression in human liver cholestasis

Journal Club 2016. 4. 29 Read More »

Journal club 2016. 04. 22.

Long-Term Activation of Group I Metabotropic Glutamate Receptors Increases Functional TRPV1- Expressing Neurons in Mouse Dorsal Root Ganglia

Takayoshi Masuoka1*, Makiko Kudo1, Junko Yoshida1, Takaharu Ishibashi1,2, Ikunobu Muramatsu1, Nobuo Kato3, Noriko Imaizumi1 and Matomo Nishio1
1 Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Japan, 2 Department
of Pharmacology, School of Nursing, Kanazawa Medical University, Uchinada, Japan, 3 Department of Physiology I, School of Medicine, Kanazawa Medical University, Uchinada, Japan

fncel-10-00079

Damaged tissues release glutamate and other chemical mediators for several hours. These chemical mediators contribute to modulation of pruritus and pain. Herein, we investigated the effects of long-term activation of excitatory glutamate receptors on functional expression of transient receptor potential vaniloid type 1 (TRPV1) in dorsal root ganglion (DRG) neurons and then on thermal pain behavior. In order to detect the TRPV1-mediated responses in cultured DRG neurons, we monitored intracellular calcium responses to capsaicin, a TRPV1 agonist, with Fura-2. Long-term (4 h) treatment with glutamate receptor agonists (glutamate, quisqualate or DHPG) increased the proportion of neurons responding to capsaicin through activation of metabotropic glutamate receptor mGluR1, and only partially through the activation of mGluR5; engagement of these receptors was evident in neurons responding to allylisothiocyanate (AITC), a transient receptor potential ankyrin type 1 (TRPA1) agonist. Increase in the proportion was suppressed by phospholipase C (PLC), protein kinase C, mitogen/extracellular signal-regulated kinase, p38 mitogen-activated protein kinase or transcription inhibitors. Whole-cell recording was performed to record TRPV1-mediated membrane current; TRPV1 current density significantly increased in the AITC-sensitive neurons after the quisqualate treatment. To elucidate the physiological significance of this phenomenon, a hot plate test was performed. Intraplantar injection of quisqualate or DHPG induced heat hyperalgesia that lasted for 4 h post injection. This chronic hyperalgesia was attenuated by treatment with either mGluR1 or mGluR5 antagonists. These results suggest that long-term activation of mGluR1/5 by peripherally released glutamate may increase the number of neurons expressing functional TRPV1 in DRG, which may be strongly associated with chronic hyperalgesia.
Keywords: metabotropic glutamate receptors, TRPV1, TRPA1, dorsal root ganglion, heat hyperalgesia

Journal club 2016. 04. 22. Read More »

Journal Club 2016. 4. 15

Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2: Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2.

Abstract

Myeloid differentiation factor 2 (MD-2) is an extracellular protein, associated with the ectodomain of TLR4, that plays a critical role in the recognition of bacterial LPS. Despite high overall structural and functional similarity, human (h) and murine (m) MD-2 exhibit several species-related differences. hMD-2 is capable of binding LPS in the absence of TLR4, whereas mMD-2 supports LPS responsiveness only when mMD-2 and mTLR4 are coexpressed in the same cell. Previously, charged residues at the edge of the LPS binding pocket have been attributed to this difference. In this study, site-directed mutagenesis was used to explore the hydrophobic residues within the MD-2 binding pocket as the source of functional differences between hMD-2 and mMD-2. Whereas decreased hydrophobicity of residues 61 and 63 in the hMD-2 binding pocket retained the characteristics of wild-type hMD-2, a relatively minor change of valine to alanine at position 135 completely abolished the binding of LPS to the hMD-2 mutant. The mutant, however, retained the LPS binding in complex with TLR4 and also cell activation, resulting in a murine-like phenotype. These results were supported by the molecular dynamics simulation. We propose that the residue at position 135 of MD-2 governs the dynamics of the binding pocket and its ability to accommodate lipid A, which is allosterically affected by bound TLR4.

Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2; Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2

Journal Club 2016. 4. 15 Read More »

2016.04.08

Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling
Sabrina Cipriani1☯, Barbara Renga2☯, Claudio D’Amore2, Michele Simonetti2, Antonio
Angelo De Tursi2, Adriana Carino2, Maria Chiara Monti3, Valentina Sepe4,
Angela Zampella4, Stefano Fiorucci2*
1 Department of Medicine University of Perugia, Perugia, Italy, 2 Department of Surgery and Biomedical
Sciences, University of Perugia, Perugia, Italy, 3 Department of Pharmacy, University of Salerno, Salerno,
Italy, 4 Department of Pharmacy, University of Naples “Federico II”, Naples, Italy

Abstract
Background & Aims
In cholestatic syndromes, body accumulation of bile acids is thought to cause itching. However,
the mechanisms supporting this effect remain elusive. Recently, GPBAR1 (TGR5) a
G-protein coupled receptor has been shown to mediate itching caused by intradermal
administration of DCA and LCA. 6α-ethyl-3α, 7α-dihydroxy-24-nor-5β-cholan-23-ol
(BAR502) is a non-bile acid dual ligand for FXR and GPBAR1.
Methods
Cholestasis was induced in wild type and GPBAR1-/- mice by administration of α-naphthylisothiocyanate (ANIT) or 17α-ethynylestradiol.
Results.
In naïve mice skin application of DCA, TLCA, 6-ECDCA, oleanolic and betulinic acid
induces a GPBAR1 dependent pruritogenic response that could be desensitized by re-challengingthe mice with the same GPBAR1 agonist. In wild type and GPBAR1-/- mice cholestasisinduced by ANIT fails to induce spontaneous itching and abrogates scratching
behavior caused by intradermal administration of DCA. In this model, co-treatment with
BAR502 increases survival, attenuates serum alkaline phosphatase levels and robustly
modulates the liver expression of canonical FXR target genes including OSTα, BSEP, SHP
and MDR1, without inducing pruritus. Betulinic acid, a selective GPBAR1 ligand, failed to
rescue wild type and GPBAR1-/- mice from ANIT cholestasis but did not induced itching. In
the 17α-ethynylestradiol model BAR502 attenuates cholestasis and reshapes bile acid pool
without inducing itching.

Impaired itching perception in murine models of cholestasis is supported by dysregulation of GPBAR1 signalling

2016.04.08 Read More »

Journal club 2016-04-01

Transient receptor potential vanilloid 4 ion channel functions as a pruriceptor in epidermal keratinocytes to evoke histaminergic itch

+ Author Affiliations


  1. Duke University, United States

Abstract

TRPV4 ion channels function in epidermal keratinocytes and in innervating sensory neurons, however, the contribution of the channel in either cell to neurosensory function remains to be elucidated. We recently reported TRPV4 as a critical component of the keratinocyte machinery that responds to UVB, and functions critically to convert the keratinocyte into a pain-generator cell after excess UVB exposure. One key mechanism in keratinocytes was increased expression and secretion of endothelin-1, which is also a known pruritogen. Here we address the question whether TRPV4 in skin keratinocytes functions in itch, as a particular form of forefront signaling in non-neural cells. Our results support this novel concept, based on attenuated scratching behavior in response to histaminergic (histamine, compound 48/80, endothelin-1), not non-histaminergic (chloroquine) pruritogens in Trpv4 keratinocyte-specific and inducible knockout mice. We demonstrate that keratinocytes rely on TRPV4 for calcium influx in response to histaminergic pruritogens. TRPV4 activation in keratinocytes evokes phosphorylation of MAP-kinase, ERK, for histaminergic pruritogens. This finding is relevant because we observed robust anti-pruritic effects with topical applications of selective inhibitors for TRPV4 and also for MEK, the kinase upstream of ERK, suggesting that calcium influx via TRPV4 in keratinocytes leads to ERK-phosphorylation, which in-turn rapidly converts the keratinocyte into an organismal itch-generator cell. In support of this concept we found that scratching behavior, evoked by direct intradermal activation of TRPV4, was critically dependent on TRPV4-expression in keratinocytes. Thus, TRPV4 functions as a pruriceptor-TRP in skin keratinocytes in histaminergic itch, a novel basic concept with translational-medical relevance.

TRPV4 in histaminergic itch

Journal club 2016-04-01 Read More »

2016.03.18

Eact, a small molecule activator of TMEM16A, activates TRPV1 and elicits pain- and itch- related behaviours

Shenbin Liu1,2,*, Jing Feng1,*, Jialie Luo1, Pu Yang1, Thomas J Brett3 and Hongzhen Hu1

BACKGROUND AND PURPOSE

TMEM16A, also known as anoctamin 1 channel, is a member of the Ca2+-activated chloride channels family and serves as a heat sensor in the primary nociceptors. Eact is a recently discovered small molecule activator of the TMEM16A channel. Here, we asked if Eact produces pain- and itch-related responses in vivo and investigated the cellular and molecular basis of Eact-elicited responses in dorsal root ganglia (DRG) neurons.

EXPERIMENTAL APPROACH
We employed behavioural testing combined with pharmacological inhibition and genetic ablation approaches to identify transient receptor potential vanilloid 1 (TRPV1) as the prominent mediator for Eact-evoked itch- or pain-related responses. We investigated the effects of Eact on TRPV1 and TMEM16A channels expressed in HEK293T cells and in DRG neurons isolated from wild type and Trpv1/ mice using Ca2+ imaging and patch-clamp recordings. We also used site-directed mutagenesis to determine the molecular basis of Eact activation of TRPV1.

KEY RESULTS
Administration of Eact elicited both itch- and pain-related behaviours. Unexpectedly, the Eact-elicited behavioural responses were dependent on the function of TRPV1, as shown by pharmacological inhibition and genetic ablation studies. Eact activated membrane currents and increased intracellular free Ca2+ in both TRPV1-expressing HEK293T cells and isolated DRG neurons in a TRPV1-dependent manner. Eact activation of the TRPV1 channel was severely attenuated by mutations disrupting the capsaicin binding sites.

CONCLUSIONS AND IMPLICATIONS
Our results suggest that Eact activates primary sensory nociceptors and produces both pain and itch responses mainly through direct activation of TRPV1 channels.

 

Eact, a small molecule activator of TMEM16A, activates TRPV1 and elicits pain- and itch- related behaviours

2016.03.18 Read More »

Scroll to Top